UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3495-3502

2000

Volltextzugriff (PDF)

Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2008-01, Vol.26 (1), p.83-89

2008

Volltextzugriff (PDF)

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1380-1390

2019

Volltextzugriff (PDF)

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1437-1443

2017

Volltextzugriff (PDF)

Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4240-4248

2020

Volltextzugriff (PDF)

Randomized Controlled Trial of Survivorship Care Plans Among Low-Income, Predominantly Latina Breast Cancer Survivors

Journal of clinical oncology, 2017-06, Vol.35 (16), p.1814-1821

2017

Volltextzugriff (PDF)

Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3093-3100

2000

Volltextzugriff (PDF)

Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2016-12, Vol.34 (36), p.4371-4380

2016

Volltextzugriff (PDF)

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

Journal of clinical oncology, 2021-09, Vol.39 (25), p.JCO2002636-2790

2021

Volltextzugriff (PDF)

Interim results from a phase I/II study of duvelisib PI3Kδγ inhibitor and nivolumab in patients with advanced unresectable melanoma who have progressed on anti-PD1 therapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9540-9540

2023

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6172-6180

2005

Volltextzugriff (PDF)

Paclitaxel, an Active Agent in Nonsquamous Carcinomas of the Uterine Cervix: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1275-1278

2001

Volltextzugriff (PDF)

Implementation of insurance marketplaces and changes in diagnosis stage in low-income cancer patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1576-1576

2021

Volltextzugriff (PDF)

CDH1 -mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.564-564

2023

Volltextzugriff (PDF)

Global oncology fellowship electives: The impact on cancer care and international collaborations

Journal of clinical oncology, 2019-12, Vol.36 (15_suppl), p.11009-11009

2019

Volltextzugriff (PDF)

Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5802-5812

Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration

2008

Volltextzugriff (PDF)

Quality of Care for Breast Cancer for Uninsured Women in California Under the Breast and Cervical Cancer Prevention Treatment Act

Journal of clinical oncology, 2010-07, Vol.28 (21), p.3479-3484

2010

Volltextzugriff (PDF)

Variation in the use of genomic testing in patients with metastatic colorectal cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15557-e15557

2021

Volltextzugriff (PDF)

LMTK3 as a novel regulator of oncogenic KIT in KIT-mutant cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11044-11044

2017

Volltextzugriff (PDF)

Longitudinal immunological responses of COVID-19 vaccination in patients with solid tumors on active treatment: A pilot study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS10618-TPS10618

2022

Volltextzugriff (PDF)

A single institution cohort of patients with classical Hodgkin lymphoma treated with brentuximab vedotin plus nivolumab

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18738-e18738

2022

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(154)

Sprache

Englisch
(154)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Oncology
(30)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Female
(27)
Middle Aged
(22)
Adult
(19)
Aged
(18)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Male
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Aged, 80 And Over
(9)
Original Reports
(9)
Treatment Outcome
(9)
Chemotherapy
(8)
Pharmacology. Drug Treatments
(8)
Survival Analysis
(8)
Tumors
(8)
Antineoplastic Agents
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations

Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)

Randomized Controlled Trial of Survivorship Care Plans Among Low-Income, Predominantly Latina Breast Cancer Survivors

Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer

Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes

Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

Interim results from a phase I/II study of duvelisib PI3Kδγ inhibitor and nivolumab in patients with advanced unresectable melanoma who have progressed on anti-PD1 therapy

Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study

Paclitaxel, an Active Agent in Nonsquamous Carcinomas of the Uterine Cervix: A Gynecologic Oncology Group Study

Implementation of insurance marketplaces and changes in diagnosis stage in low-income cancer patients

CDH1 -mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS)

Global oncology fellowship electives: The impact on cancer care and international collaborations

Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials

Quality of Care for Breast Cancer for Uninsured Women in California Under the Breast and Cervical Cancer Prevention Treatment Act

Variation in the use of genomic testing in patients with metastatic colorectal cancer

LMTK3 as a novel regulator of oncogenic KIT in KIT-mutant cancers

Longitudinal immunological responses of COVID-19 vaccination in patients with solid tumors on active treatment: A pilot study

A single institution cohort of patients with classical Hodgkin lymphoma treated with brentuximab vedotin plus nivolumab

Aktive Filter

Suchergebnisse filtern